Back to Rankings

GENB

Generate BiomedicinesN/A
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-03
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
GENB vs peer average
50/100
GENB vs. peer average (N/A vs. C)
Grade spread
B 2 · C 2 · D 3 · F 1
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

HCM is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $2.07B

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerHCMHUTCHMED (China)
GENB
Generate Biomedicines
HCM
HUTCHMED (China)
Grade
N/A
D
Momentum
78
36
Value
-
44
Sentiment
-
-
Setup Bias
Net Bearish
-
Market Cap
-
-
Posture
Unrated
Defensive

Grade position vs HCM

GENB / HCM
Grade Position
In line
GENB vs. peer average (N/A vs. C)
50/100
Momentum
78
GENB
Value
-
-
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GENB
1
HCM
HUTCHMED (China) Ltd ADR
D
40/100
-
2
KOD
Kodiak Sciences Inc Common
B
80/100
-
3
PHVS
Pharvaris NV Common
C
60/100
-
4
BCRX
BioCryst Pharmaceuticals Inc Common
B
80/100
-
5
AUPH
Aurinia Pharmaceuticals Inc Common
C
60/100
-
HCM is the first peer returned for this comparison set.